Study on effectiveness of behavioral activation therapy program for depression in advanced cancer patients: a pilot-multicenter randomized controlled trial - pilot BA-RCT

Hirayama Takatoshi0 个研究点目标入组 38 人开始时间: 2022年3月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Physical condition: Those who meet the following (a) to (c).
•(a) Cancer patients who have been diagnosed or have been notified of recurrence for more than 1 month and whose clinical stages are stage III or IV and whose attending physician has determined that they cannot aim for radical cure.
•(b) Expected prognosis is expected to be about 1 year or more
•(c) Those who can participate in all sessions of the program
•2. Patients with depression: 16 points or more in Beck Depression Inventory-II (BDI-II)
•3. Age: 20-64 years old, 65 years old and over with MMSE-J 24 points or more
•4. PS (Performance status): ECOG performance status score is 0 or 1
•5. Patients who can speak Japanese
•6. Patients who have consented to participate in the study and wish to continue intervention

•1. Patients with severe physical or psychological symptoms (cognitive dysfunction, impaired consciousness, severe depression with psychotic symptoms, imminent suicidal ideation, and history of suicide attempt)
•2. Patients who have received psychological intervention, such as behavioral activation, by mental health professionals before enrollment
•3. Patients taking or planning to use any psychotropic drug during the program
•4. Patients with substance dependence based on the diagnostic criteria of DSM-5
•5. Patients who are deemed to have difficulty in participating this program by the attending physician or the researcher due to other reasons.

发起方

Hirayama Takatoshi